These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21123980)

  • 1. Efficacy of revascularization surgery for moyamoya syndrome associated with Graves' disease.
    Endo H; Fujimura M; Niizuma K; Shimizu H; Tominaga T
    Neurol Med Chir (Tokyo); 2010; 50(11):977-83. PubMed ID: 21123980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.
    Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperperfusion after Revascularization for Quasi-moyamoya Disease Associated with Graves' Disease:A Case Report].
    Shimonaga K; Mitsuhara T; Hosogai M; Kawasumi T
    No Shinkei Geka; 2018 Jun; 46(6):501-508. PubMed ID: 29930211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
    Ohba S; Nakagawa T; Murakami H
    Neurosurg Rev; 2011 Jul; 34(3):297-304; discussion 304. PubMed ID: 21424208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
    Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the revascularization surgery for adult-onset moyamoya disease with the progression of cerebrovascular lesions.
    Narisawa A; Fujimura M; Tominaga T
    Clin Neurol Neurosurg; 2009 Feb; 111(2):123-6. PubMed ID: 18995956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moyamoya disease concurrent with Graves' disease treated by direct bypass: clinical features and treatment strategies.
    Ryu B; Kawamata T; Yamaguchi K; Kawashima A; Ono M; Okada Y
    Acta Neurochir (Wien); 2015 Jul; 157(7):1095-102. PubMed ID: 25929211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres.
    Fujimura M; Tominaga T
    Neurol Med Chir (Tokyo); 2012; 52(5):327-32. PubMed ID: 22688070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
    Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management.
    Im SH; Oh CW; Kwon OK; Kim JE; Han DH
    J Neurosurg; 2005 Jun; 102(6):1013-7. PubMed ID: 16028759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus: report of two cases.
    Suzuki S; Mitsuyama T; Horiba A; Fukushima S; Hashimoto N; Kawamata T
    Clin Neurol Neurosurg; 2011 May; 113(4):325-9. PubMed ID: 21215511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya syndrome associated with Graves' disease: a case report and review of the literature.
    Malik S; Russman AN; Katramados AM; Silver B; Mitsias PD
    J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):528-36. PubMed ID: 21130668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial moyamoya disease associated with Graves' disease in a mother and daughter. Two case reports.
    Tokimura H; Tajitsu K; Takashima H; Hirayama T; Tsuchiya M; Takayama K; Arita K
    Neurol Med Chir (Tokyo); 2010; 50(8):668-74. PubMed ID: 20805652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
    Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
    World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.